Literature DB >> 2341341

Operation Everest II: neuromuscular performance under conditions of extreme simulated altitude.

S H Garner1, J R Sutton, R L Burse, A J McComas, A Cymerman, C S Houston.   

Abstract

The force output of the ankle dorsiflexors was studied during a 40-day simulated ascent of Mt. Everest in a hypobaric chamber; both electrically activated and maximal voluntary contractions (MVCs) were employed. The purpose of this study was to establish whether, under conditions of progressive chronic hypoxia, there was a decrease in muscle force output and/or increased fatigability. We also attempted to identify the main site of any failure, i.e., central nervous system, neuromuscular junction, or muscle fiber. Muscle twitch torque (Pt), tetanic torque (Po), MVC torque, and evoked muscle compound action potential (M wave) were monitored during 205-s exercise periods in five subjects at three simulated altitudes (760, 335, and 282 Torr). All three types of torque measurement were well preserved at the three altitudes. In some subjects, the responses to stimuli interpolated during repeated MVCs provided evidence of "central" fatigue at altitude. In addition, the rate of fatigue during 20-Hz electrical stimulation was greater (P less than 0.01) at altitude and there was increased fatigability of the twitch (P less than 0.025); however, the M wave amplitude was maintained. We conclude that central motor drive becomes more precarious at altitude and is associated with increased muscle fatigue at low excitation frequencies; the latter is the result, in part, of chronic hypoxia and occurs in the muscle fiber interior because no impairment in neuromuscular transmission could be demonstrated.

Entities:  

Mesh:

Year:  1990        PMID: 2341341     DOI: 10.1152/jappl.1990.68.3.1167

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  19 in total

1.  Modulation of exercise-induced spinal loop properties in response to oxygen availability.

Authors:  Thomas Rupp; Sébastien Racinais; Aurélien Bringard; Thomas Lapole; Stéphane Perrey
Journal:  Eur J Appl Physiol       Date:  2014-11-01       Impact factor: 3.078

2.  Postural instability at a simulated altitude of 5,000 m before and after an expedition to Mt. Cho-Oyu (8,201 m).

Authors:  Masako Hoshikawa; Shiori Hashimoto; Takashi Kawahara; Rika Ide
Journal:  Eur J Appl Physiol       Date:  2010-06-13       Impact factor: 3.078

3.  Matched adaptations of electrophysiological, physiological, and histological properties of skeletal muscles in response to chronic hypoxia.

Authors:  Marion Faucher; Chantal Guillot; Tanguy Marqueste; Nathalie Kipson; Marie-Hélène Mayet-Sornay; Dominique Desplanches; Yves Jammes; Monique Badier
Journal:  Pflugers Arch       Date:  2004-12-10       Impact factor: 3.657

Review 4.  Neuropsychological functioning associated with high-altitude exposure.

Authors:  Javier Virués-Ortega; Gualberto Buela-Casal; Eduardo Garrido; Bernardino Alcázar
Journal:  Neuropsychol Rev       Date:  2004-12       Impact factor: 7.444

Review 5.  Lactate during exercise at high altitude.

Authors:  B Kayser
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

6.  Alpha-motoneuron excitability at high altitude.

Authors:  B Kayser; R Bökenkamp; T Binzoni
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

Review 7.  Lactic acid and exercise performance : culprit or friend?

Authors:  Simeon P Cairns
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

8.  Operation Everest II.

Authors:  Peter D Wagner
Journal:  High Alt Med Biol       Date:  2010       Impact factor: 1.981

9.  On the mechanisms that limit oxygen uptake during exercise in acute and chronic hypoxia: role of muscle mass.

Authors:  José A L Calbet; Göran Rådegran; Robert Boushel; Bengt Saltin
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

10.  Chronic hypobaric hypoxia does not affect electro-mechanical muscle activities during sustained maximal isometric contractions.

Authors:  Fabio Esposito; Claudio Orizio; Giovanni Parrinello; Arsenio Veicsteinas
Journal:  Eur J Appl Physiol       Date:  2003-08-22       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.